Treatment options for insomnia

South African Family Practice

Volumn 49, Issue 8, 2007, Pages 34-41

  Ramakrishnan, Kalyanakrishnan ^a,b   Scheid, Dewey C ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIHISTAMINIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; DIPHENHYDRAMINE; DOXEPIN; DOXYLAMINE; ESTAZOLAM; ESZOPICLONE; FLURAZEPAM; GLUTAMINE; HYDROXYZINE; HYPERICUM PERFORATUM EXTRACT; KAVA; LAVENDER OIL; MELATONIN; MIRTAZAPINE; NICOTINIC ACID; OPIATE; QUAZEPAM; RAMELTEON; TEMAZEPAM; TRAZODONE; TRIAZOLAM; TRYPTOPHAN; VALERIAN; ZALEPLON; ZOLPIDEM;

ABDOMINAL PAIN; AGRANULOCYTOSIS; ALCOHOL ABUSE; AMNESIA; ANTEROGRADE AMNESIA; BACKACHE; CARDIOTOXICITY; CIRCADIAN RHYTHM; COGNITIVE THERAPY; COLOR VISION; DELUSION; DEPRESSION; DIET SUPPLEMENTATION; DIZZINESS; DRUG SAFETY; DYSPNEA; EDEMA; EXERCISE; FACE EDEMA; FATIGUE; FOOD AND DRUG ADMINISTRATION; FUNCTIONAL ASSESSMENT; GRIEF; HALLUCINATION; HEADACHE; HUMAN; HYPERKINESIA; HYPOKINESIA; INCREASED APPETITE; INSOMNIA; IRRITABILITY; LAVENDER; LIVER FAILURE; LIVER TOXICITY; REBOUND INSOMNIA; RELAXATION TRAINING; REM SLEEP; RESTLESS LEGS SYNDROME; REVIEW; SEDATION; SEIZURE; SEROTONIN SYNDROME; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP; SLEEP DISORDER; SOMNOLENCE; STRESS; SUICIDAL IDEATION; TASTE DISORDER; UNSPECIFIED SIDE EFFECT;

EID: 36348979308     PISSN: 20786190     EISSN: 20786204     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Sateia MJ, Doghramji K, Hauri PJ, Morin CM. Evaluation of chronic insomnia. An American Academy of Sleep Medicine review. Sleep 2000;23:243-308.
2. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002;6:97-111.
3. NIH state-of-the-science conference statement on manifestations and management of chronic insomnia in adults. NIH Consens State Sci Statements 2005;22: 1-30. Accessed March 20, 2007, at: http: //consensus.nih.gov/2005/ 2005InsomniaSO S026main.htm.
4. Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, Ospina M, et al. Manifestations and management of chronic insomnia in adults. Evid Rep Technol Assess (Summ) 2005;125:1-10.
5. International Classification of Sleep Disorders: Diagnostic and Coding Manual. 2nd ed. Westchester, Ill.: American Academy of Sleep Medicine, 2005.
6. Thase ME. Correlates and consequences of chronic insomnia. Gen Hosp Psychiatry 2005;27:100-12.
7. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach. CMAJ 2000;162: 216-20.
8. Kupfer DJ, Reynolds CF III. Management of insomnia. N Engl J Med 1997;336:341-6.
9. Sateia MJ, Pigeon WR. Identification and management of insomnia. Med Clin North Am 2004;88:567-96.
10. Chesson A Jr, Hartse K, Anderson WM, Davila D, Johnson S, Littner M, et al. Practice parameters for the evaluation of chronic insomnia. An American Academy of Sleep Medicine report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 2000;23:237-41.
11. Practice parameters for the use of polysomnography in the evaluation of insomnia. Standards of Practice Committee of the American Sleep Disorders Association. Sleep 1995;18:55-7.
12. Montgomery P, Dennis J. Cognitive behavioural interventions for sleep problems in adults aged 60+. Cochrane Database Syst Rev 2003;(1):CD003161.
13. Morin CM, Hauri PJ, Espie CA, Spielman AJ, Buysse DJ, Bootzin RR. Nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine review. Sleep 1999;22:1134-56.
14. Murtagh DR, Greenwood KM. Identifying effective psychological treatments for insomnia: a meta-analysis. J Consult Clin Psychol 1995;63:79-89.
15. Smith MT, Perlis ML, Park A, Smith MS, Pennington J, Giles DE, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 2002;159:5-11.
16. King AC, Oman RF, Brassington GS, Bliwise DL, Haskell WL. Moderate-intensity exercise and self-rated quality of sleep in older adults. A randomized controlled trial. JAMA 1997;277:32-7.
17. Morin AK. Strategies for treating chronic insomnia. Am J Manag Care 2006;12(8 suppl):S230-45.
18. Leopando ZE, Dela Cruz A, Limoso DD, Marcos JA, Alba ME. Clinical practice guidelines on the diagnosis and management of insomnia in family practice: part 2. Asia Pacific Fam Med 2003;2:45-50.
19. Cauffield JS. Supplement used to treat sleep disorders. U.S. Pharmacist. Accessed March 20, 2007, at: http://www.uspharmacist.com/oldformat.asp?url= newlook/files/Comp/sleep.htm
20. Buscemi N, Vandermeer B, Pandya R, Hooton N, Tjosvold L, Hartling L, et al. Melatonin for treatment of sleep disorders. Evid Rep Technol Assess (Summ) 2004;108:1-7.
21. Anxiolytics, sedatives and hypnotics. In: McEvoy GK. AHFS Drug Information 2005. Bethesda, Md.: American Society of Health System Pharmacists, 2005:2386-92. Accessed March 20, 2007, at: http: //www.ashp.org/mngrphs/AHFS.
22. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 2000;162:225-33.
23. National Institute for Clinical Excellence. Quick reference guide: zaleplon, Zolpidem and zopiclone for the short-term management of insomnia. Accessed March 20, 2007, at: http://www.nice.org.uk/pdf/ TA077quickrefguide.pdf.
24. Baillargeon L, Landreville P, Verreault R, Beauchemin J, Gregoire JP, Morin CM. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial. CMAJ 2003;169:1015-20.
25. Hemmelgarn B, Suissa S, Huang A, Boivin JF, Pinard G. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 1997; 278:27-31.
26. Thomas RE. Benzodiazepine use and motor vehicle accidents. Systematic review of reported association. Can Fam Physician 1998;44:799-808.
27. Panneman MJ, Goettsch WG, Kramarz P, Herings RM. The costs of benzodiazepine-associated hospital-treated fall injuries in the EU: a Pharmo study. Drugs Aging 2003;20: 833-9.
28. Toner LC, Tsambiras BM, Catalano G, Catalano MC, Cooper DS. Central nervous system side effects associated with Zolpidem treatment. Clin Neuropharmacol 2000;23: 54-8.
29. Scharf MB, Roth T, Vogel GW, Walsh JK. A multicenter, placebo-controlled study evaluating Zolpidem in the treatment of chronic insomnia. J Clin Psychiatry 1994;55:192-9.
30. Drover DR. Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, Zolpidem and zopiclone. Clin Pharmacokinet 2004;43:227-38.
31. Krystal AD, Walsh JK, Laska E, Caron J, Amato DA, Wessel TC, et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 2003;26:793-9.
32. Nguyen NN, Yu SS, Song JC. Ramelteon: a novel melatonin receptor agonist for the treatment of insomnia. Formulary 2005;40: 146-55.
33. Ward CR. Ramelteon (Rozerem) for insomnia. Am Fam Physician 2006; 73:1437-8.
34. Buscemi N, Vandermeer B, Friesen C, Biali L, Tubman M, Ospina M, et al. Manifestations and management of chronic insomnia in adults. Evidence report/technology assessment no. 125. AHRQ Publication no. 05-E021-2. Rockville, Md.: Agency for Healthcare Research and Quality, 2005.
35. Nowell PD, Mazumdar S, Buysse DJ, Dew MA, Reynolds CF III, Kupfer DJ. Benzodiazepines and Zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA 1997;278:2170-7.
36. Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005;331:1169.
37. Darcourt G, Pringuey D, Salliere D, Lavoisy J. The safety and tolerability of zolpidem-an update. J Psychopharmacol 1999;13:81-93.
38. Bell L, Tousignant P. The treatment of insomnia in the elderly: a cost-utility analysis [meeting abstract]. Med Decis Making 1999;18:487.